These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Protection against human immunodeficiency virus type 2 and simian immunodeficiency virus in macaques vaccinated against human immunodeficiency virus type 2. Biberfeld G; Thorstensson R; Putkonen P AIDS Res Hum Retroviruses; 1996 Mar; 12(5):443-6. PubMed ID: 8882330 [No Abstract] [Full Text] [Related]
7. A noninfectious simian/human immunodeficiency virus DNA vaccine that protects macaques against AIDS. Singh DK; Liu Z; Sheffer D; Mackay GA; Smith M; Dhillon S; Hegde R; Jia F; Adany I; Narayan O J Virol; 2005 Mar; 79(6):3419-28. PubMed ID: 15731236 [TBL] [Abstract][Full Text] [Related]
8. [Live attenuated viruses: a new strategy for vaccination against AIDS]. Molina JM Pathol Biol (Paris); 1993 Jun; 41(6):513-4. PubMed ID: 8247628 [No Abstract] [Full Text] [Related]
9. AIDS vaccine developments. Le Grand R; Vaslin B; Vogt G; Roques P; Humbert M; Dormont D Nature; 1992 Feb; 355(6362):684. PubMed ID: 1741053 [No Abstract] [Full Text] [Related]
10. SIV vaccines, 1991--a year in review. Gardner MB; Hu SL AIDS; 1991; 5 Suppl 2():S115-27. PubMed ID: 1845043 [No Abstract] [Full Text] [Related]
11. Challenges and strategies for AIDS vaccine development. Oxford JS; Frezza P; Race E Vaccine; 1993; 11(6):612-4. PubMed ID: 8100664 [TBL] [Abstract][Full Text] [Related]
14. Dominant induction of vaccine antigen-specific cytotoxic T lymphocyte responses after simian immunodeficiency virus challenge. Takahara Y; Matsuoka S; Kuwano T; Tsukamoto T; Yamamoto H; Ishii H; Nakasone T; Takeda A; Inoue M; Iida A; Hara H; Shu T; Hasegawa M; Sakawaki H; Horiike M; Miura T; Igarashi T; Naruse TK; Kimura A; Matano T Biochem Biophys Res Commun; 2011 May; 408(4):615-9. PubMed ID: 21531211 [TBL] [Abstract][Full Text] [Related]
15. Live virus shows promise as AIDS vaccine. Minn Med; 1993 Feb; 76(2):52. PubMed ID: 8433695 [No Abstract] [Full Text] [Related]
16. A subunit vaccine consisting of gp130 oligomers but not of gp130 monomers protects rhesus macaques against productive infection with SIVmac32H. Petry H; Stahl-Hennig C; Dittmer U; Jones D; Farrar G; Wachter H; Fuchs D; Nisslein T; Jurkiewicz E; Hunsmann G; Lüke W AIDS; 1998 Feb; 12(3):329-30. PubMed ID: 9518000 [No Abstract] [Full Text] [Related]
17. SIV and FIV vaccine studies at UC Davis: 1991 update. Gardner M; Yamamoto J; Marthas M; Miller C; Jennings M; Rosenthal A; Luciw P; Planelles V; Yilma T; Giavedoni L AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1495-8. PubMed ID: 1334682 [No Abstract] [Full Text] [Related]
18. Cytotoxic T lymphocytes in AIDS pathogenesis: lessons to be learned from the macaque model of simian immunodeficiency virus infection. Geretti AM; Hulskotte E; Osterhaus AD J Gen Virol; 1998 Mar; 79 ( Pt 3)():415-21. PubMed ID: 9519818 [No Abstract] [Full Text] [Related]
19. Vaccine studies with the 32H reisolate of SIVmac251: an overview. Cranage M; Stott J; Mills K; Ashworth T; Taffs F; Farrar G; Chan L; Dennis M; Putkonen P; Biberfeld G AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1479-81. PubMed ID: 1466987 [No Abstract] [Full Text] [Related]
20. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P). Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]